Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTAL FORMS OF TRIAZINE DIONE DERIVATIVE AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2023/222103
Kind Code:
A1
Abstract:
The present disclosure relates to crystal forms of a triazine dione derivative and a preparation method therefor. Specifically, the present disclosure relates to different crystal forms of (S)-6-((1-(2-fluoro-5-methylphenyl)ethyl)amino)-3-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazine-2,4(1H,3H)-dione and a preparation method therefor. The crystal forms of (S)-6-((1-(2-fluoro-5-methylphenyl)ethyl)amino)-3-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazine-2,4(1H,3H)-dione provided by the present disclosure have good stability and can be better used for clinical treatment.

Inventors:
ZHANG BAOLEI (CN)
XI ZHUOXUN (CN)
FENG JUN (CN)
ZHAO MIAOMIAO (CN)
DU ZHENXING (CN)
Application Number:
PCT/CN2023/095172
Publication Date:
November 23, 2023
Filing Date:
May 19, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D405/04; A61K31/53; A61P9/04; A61P9/10; C07D251/40; C07D407/02
Domestic Patent References:
WO2022105852A12022-05-27
WO2022194236A12022-09-22
Foreign References:
CN105473576A2016-04-06
CA1036491A1978-08-15
US20140378491A12014-12-25
GB1435585A1976-05-12
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: